These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 21511917

  • 1. 15-Deoxy-delta12,14-prostaglandin J2-glycerol ester, a putative metabolite of 2-arachidonyl glycerol, activates peroxisome proliferator activated receptor gamma.
    Raman P, Kaplan BL, Thompson JT, Vanden Heuvel JP, Kaminski NE.
    Mol Pharmacol; 2011 Jul; 80(1):201-9. PubMed ID: 21511917
    [Abstract] [Full Text] [Related]

  • 2. 15-Deoxy-Δ¹²,¹⁴-prostaglandin J₂-glycerol, a putative metabolite of 2-arachidonyl glycerol and a peroxisome proliferator-activated receptor γ ligand, modulates nuclear factor of activated T cells.
    Raman P, Kaplan BL, Kaminski NE.
    J Pharmacol Exp Ther; 2012 Sep; 342(3):816-26. PubMed ID: 22700433
    [Abstract] [Full Text] [Related]

  • 3. Interleukin-2 suppression by 2-arachidonyl glycerol is mediated through peroxisome proliferator-activated receptor gamma independently of cannabinoid receptors 1 and 2.
    Rockwell CE, Snider NT, Thompson JT, Vanden Heuvel JP, Kaminski NE.
    Mol Pharmacol; 2006 Jul; 70(1):101-11. PubMed ID: 16611855
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of interleukin-1beta-induced cyclooxygenase 2 expression in human synovial fibroblasts by 15-deoxy-Delta12,14-prostaglandin J2 through a histone deacetylase-independent mechanism.
    Farrajota K, Cheng S, Martel-Pelletier J, Afif H, Pelletier JP, Li X, Ranger P, Fahmi H.
    Arthritis Rheum; 2005 Jan; 52(1):94-104. PubMed ID: 15641079
    [Abstract] [Full Text] [Related]

  • 5. 15-Deoxy-Delta12,14-prostaglandin J(2) induces death receptor 5 expression through mRNA stabilization independently of PPARgamma and potentiates TRAIL-induced apoptosis.
    Nakata S, Yoshida T, Shiraishi T, Horinaka M, Kouhara J, Wakada M, Sakai T.
    Mol Cancer Ther; 2006 Jul; 5(7):1827-35. PubMed ID: 16891469
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism.
    Grau R, Iñiguez MA, Fresno M.
    Cancer Res; 2004 Aug 01; 64(15):5162-71. PubMed ID: 15289320
    [Abstract] [Full Text] [Related]

  • 7. Nanomolar and micromolar effects of 15-deoxy-delta 12,14-prostaglandin J2 on amnion-derived WISH epithelial cells: differential roles of peroxisome proliferator-activated receptors gamma and delta and nuclear factor kappa B.
    Berry EB, Keelan JA, Helliwell RJ, Gilmour RS, Mitchell MD.
    Mol Pharmacol; 2005 Jul 01; 68(1):169-78. PubMed ID: 15821150
    [Abstract] [Full Text] [Related]

  • 8. 15-Deoxy-delta12,14-PGJ2 inhibits IL-6-induced Stat3 phosphorylation in lymphocytes.
    Kim HJ, Rho YH, Choi SJ, Lee YH, Cheon H, Um JW, Sohn J, Song GG, Ji JD.
    Exp Mol Med; 2005 Jun 30; 37(3):179-85. PubMed ID: 16000871
    [Abstract] [Full Text] [Related]

  • 9. The cyclopentenone-type prostaglandin 15-deoxy-delta 12,14-prostaglandin J2 inhibits CD95 ligand gene expression in T lymphocytes: interference with promoter activation via peroxisome proliferator-activated receptor-gamma-independent mechanisms.
    Cippitelli M, Fionda C, Di Bona D, Lupo A, Piccoli M, Frati L, Santoni A.
    J Immunol; 2003 May 01; 170(9):4578-92. PubMed ID: 12707336
    [Abstract] [Full Text] [Related]

  • 10. Upregulation of MIP-2 (CXCL2) expression by 15-deoxy-Delta(12,14)-prostaglandin J(2) in mouse peritoneal macrophages.
    Kim HY, Kim HS.
    Immunol Cell Biol; 2007 Jan 01; 85(1):60-7. PubMed ID: 17130903
    [Abstract] [Full Text] [Related]

  • 11. 15-Deoxy-delta12,14-prostaglandin-J(2) up-regulates cyclooxygenase-2 but inhibits prostaglandin-E(2) production through a thiol antioxidant-sensitive mechanism.
    Reyes-Martin P, Ramirez-Rubio S, Parra-Cid T, Bienes-Martínez R, Lucio-Cazana J.
    Pharmacol Res; 2008 May 01; 57(5):344-50. PubMed ID: 18456507
    [Abstract] [Full Text] [Related]

  • 12. The 15-deoxy-Delta12,14-prostaglandin J2 inhibits LPS-stimulated AKT and NF-kappaB activation and suppresses interleukin-6 in osteoblast-like cells MC3T3E-1.
    Jung WK, Park IS, Park SJ, Yea SS, Choi YH, Oh S, Park SG, Choi IW.
    Life Sci; 2009 Jul 03; 85(1-2):46-53. PubMed ID: 19409914
    [Abstract] [Full Text] [Related]

  • 13. 15-Deoxy-Delta12,14-prostaglandin J2 inhibits IL-1beta-induced cyclooxygenase-2 expression in mesangial cells.
    Sawano H, Haneda M, Sugimoto T, Inoki K, Koya D, Kikkawa R.
    Kidney Int; 2002 Jun 03; 61(6):1957-67. PubMed ID: 12028436
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of trail gene expression by cyclopentenonic prostaglandin 15-deoxy-delta12,14-prostaglandin J2 in T lymphocytes.
    Fionda C, Nappi F, Piccoli M, Frati L, Santoni A, Cippitelli M.
    Mol Pharmacol; 2007 Nov 03; 72(5):1246-57. PubMed ID: 17673570
    [Abstract] [Full Text] [Related]

  • 15. Oxidized low density lipoprotein activates peroxisome proliferator-activated receptor-alpha (PPARalpha) and PPARgamma through MAPK-dependent COX-2 expression in macrophages.
    Taketa K, Matsumura T, Yano M, Ishii N, Senokuchi T, Motoshima H, Murata Y, Kim-Mitsuyama S, Kawada T, Itabe H, Takeya M, Nishikawa T, Tsuruzoe K, Araki E.
    J Biol Chem; 2008 Apr 11; 283(15):9852-62. PubMed ID: 18208815
    [Abstract] [Full Text] [Related]

  • 16. 15-deoxy-Delta12,14-prostaglandin J2 inhibits glucocorticoid binding and signaling in macrophages through a peroxisome proliferator-activated receptor gamma-independent process.
    Cheron A, Peltier J, Perez J, Bellocq A, Fouqueray B, Baud L.
    J Immunol; 2004 Jun 15; 172(12):7677-83. PubMed ID: 15187150
    [Abstract] [Full Text] [Related]

  • 17. Contrasting effects of peroxisome-proliferator-activated receptor (PPAR)gamma agonists on membrane-associated prostaglandin E2 synthase-1 in IL-1beta-stimulated rat chondrocytes: evidence for PPARgamma-independent inhibition by 15-deoxy-Delta12,14prostaglandin J2.
    Bianchi A, Moulin D, Sebillaud S, Koufany M, Galteau MM, Netter P, Terlain B, Jouzeau JY.
    Arthritis Res Ther; 2005 Jun 15; 7(6):R1325-37. PubMed ID: 16277686
    [Abstract] [Full Text] [Related]

  • 18. 15-Deoxy-Δ(12,14)-prostaglandin J2 inhibits IL-13 production in T cells via an NF-κB-dependent mechanism.
    Doyle MC, Tremblay S, Dumais N.
    Biochem Biophys Res Commun; 2013 Feb 15; 431(3):472-7. PubMed ID: 23333326
    [Abstract] [Full Text] [Related]

  • 19. Cytotoxicity of 15-deoxy-Δ(12,14)-prostaglandin J(2) through PPARγ-independent pathway and the involvement of the JNK and Akt pathway in renal cell carcinoma.
    Fujita M, Tohji C, Honda Y, Yamamoto Y, Nakamura T, Yagami T, Yamamori M, Okamura N.
    Int J Med Sci; 2012 Feb 15; 9(7):555-66. PubMed ID: 22991494
    [Abstract] [Full Text] [Related]

  • 20. Dexmedetomidine inhibits LPS-induced inflammatory responses through peroxisome proliferator-activated receptor gamma (PPARγ) activation following binding to α2 adrenoceptors.
    Fujimoto M, Higuchi H, Honda-Wakasugi Y, Miyake S, Nishioka Y, Yabuki-Kawase A, Maeda S, Miyawaki T.
    Eur J Pharmacol; 2021 Feb 05; 892():173733. PubMed ID: 33220278
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.